DVA DaVita Inc. Common Stock

NYSE · US · Healthcare · Medical Care Facilities · davita.com

178.69USD+1.33%Mkt Cap: 11.47B $P/E: 15.143d ago

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis…

Industry Peers

Medical Care Facilities

Screen all

HCA

HCA Healthcare, Inc. Common Stock

$94.66BUSDP/E 14.3

FRE

Fresenius SE & Co. KGaA

$26.85BUSDP/E 15.8

THC

Tenet Healthcare Corporation Common Stock

$20.82BUSDP/E 10.0

FME

Fresenius Medical Care AG

$11.75BUSDP/E 12.1

FMS

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

$11.84BUSDP/E 11.8

EHC

Encompass Health Corporation Common Stock

$11.82BUSDP/E 20.0

UHS

Universal Health Services, Inc. Common Stock

$10.36BUSDP/E 7.2

ENSG

The Ensign Group, Inc. - Common Stock

$10.01BUSDP/E 26.9

PACS

PACS Group, Inc. Common Stock

Concentra Group Holdings Parent, Inc. Common Stock

$4.55BUSDP/E 23.0

LFST

LifeStance Health Group, Inc. - Common Stock

National HealthCare Corporation Common Stock

$3.57BUSDP/E 25.6

OPCH

Option Care Health, Inc. - Common Stock

$3.39BUSDP/E 17.2

AVAH

Aveanna Healthcare Holdings Inc. - Common Stock

$2.75BUSDP/E 10.0

GRDN

Guardian Pharmacy Services, Inc. Class A Common Stock

$2.68BUSDP/E 40.8

ACHC

Acadia Healthcare Company, Inc. - Common Stock

$2.61BUSD

BKD

Brookdale Senior Living Inc. Common Stock

$2.59BUSD

Pediatrix Medical Group, Inc. Common Stock

$2.11BUSDP/E 12.4

Key Statistics

Company

Market Cap11.47B USD

Enterprise Value25.96B USD

Revenue (TTM)14.01B USD

Gross Profit4.40B USD

Net Income (TTM)746.80M USD

Revenue/Share204.69 USD

Last Price178.69 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees78.0K

CountryUS

SectorHealthcare

IndustryMedical Care Facilities

ISIN—

Valuation

P/E (Trailing)15.14

P/E (Forward)10.36

PEG0.43

EV/EBITDA9.19

EV/Revenue1.85

P/S0.82

P/B-14.94

EPS (TTM)11.80

EPS (Forward)17.25

52W Range

101.0053% of range247.49

52W High247.49 USD

52W Low101.00 USD

Profitability

Gross Margin32.25%

Oper. Margin16.06%

EBITDA Margin20.17%

Profit Margin5.47%

ROE-114.70%

ROA4.27%

Growth

Revenue Growth5.20%

Earnings Growth55.80%

Cash Flow & Leverage

Operating CF1.89B USD

CapEx (TTM)575.86M USD

FCF Margin7.44%

FCF Yield9.09%

Net Debt12.72B USD

Net Debt/EBITDA4.50

Balance Sheet

Debt/Equity-19.77

Current Ratio1.47

Quick Ratio1.33

Book Value/Sh-11.96 USD

Cash/Share10.80 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split2:1

Split DateSep 9, 2013

Analyst Consensus

Rating2.4 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)219.86 USD

Upside (mean)+23.0%

Target Range165.00 USD – 270.00 USD

165.00+23.0% to mean270.00

# Analysts7

Ownership

Shares Out.64.19M

Float33.93M

Insiders46.91%

Institutions48.35%

Short Interest

Short Ratio7.2d

Short % Float13.25%

Short % Out.6.74%

Shares Short4.30M

Short (prev mo.)4.00M

Technical

SMA 50190.58 (-6.2%)

SMA 200169.78 (+5.2%)

Beta0.83

S&P 52W Chg14.16%

Avg Vol (30d)663.79K

Avg Vol (10d)735.61K

Technical Indicators

RSI (14)44.4

MACD-3.4368

MACD Signal-3.5148

MACD Hist.+0.0780

BB Upper192.21 USD

BB Middle181.83 USD

BB Lower171.44 USD

BB Width11.42%

ATR (14)5.341 USD

Vol Ratio (20d)0.62x